agilon health (AGL) Stock: Buy, Sell, or Hold?

AGL - agilon health, inc.

SERVICES-MISC HEALTH & ALLIED SERVICES, NEC
$89.77
-2.83 (-3.06%) â–ŧ
5d: +3.8%
30d: +4.07%
90d: -22.72%
WAIT
LOW Confidence
Protect Your AGL Gains
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 03, 2026

Get Alerted When AGL Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
â„šī¸ NEUTRAL: AGL is fairly priced but lacks strong directional signals. At -4.1% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$72.00
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$44.71
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: AGL is currently trading at $89.77, which is considered slightly low relative to its 30-day fair value range of $87.76 to $97.28. From a valuation perspective, the stock is trading at a discount (Forward PE: 43.7) compared to its historical average (49.5). Remarkably, the market is currently pricing in an annual earnings decline of 4.1% over the next few years. This pessimistic expectation contrasts with the company's recent 301.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, AGL is in a strong downtrend. Immediate support is located at $82.61, while resistance sits at $97.26. Short-term momentum is weak, with the stock down 3.1% recently.

Market Sentiment: AGL scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (5th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $115.08 (+28.2%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY LOW
Historical Trading Range $87.76 - $97.28
Company Quality Score 51/100 (HOLD)
Options IV Signal 5th percentile (LOW)
Volume Confirmation HIGH
Confidence Score 88.5%

Protect Your Profits

Holding AGL? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Options cheap (IV 5th percentile)
  • BULLISH: Strong technical setup (68/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-3.1%)
  • BULLISH: Trading 28.2% below Wall St target ($115.08)
  • WARNING: Composite score 51/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $87.76 - $97.28
Current vs Trading Range SLIGHTLY LOW
Expected Move (7 Days) Âą$9.97 (11.1%)

Support & Resistance Levels

Support Level $82.61
Resistance Level $97.26
Current Trend Strong Downtrend
Technical data as of Sep 11, 2026

Fundamental Context

Forward P/E (Next Year Est.) 43.68
Wall Street Target $115.08 (+28.2%)
Revenue Growth (YoY) 7.2%
Earnings Growth (YoY) 301.0%
Profit Margin -3.9%
Valuation Discount vs History -4.1% cheaper
PE vs Historical 43.7 vs 49.5 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -4.1% (market-implied from PE analysis)
1-Year Target $86.09 (-4%)
2-Year Target $82.56 (-8%)
3-Year Target $79.17 (-12%)
3-Yr Target (if PE normalizes) (PE: 44→50) $89.73 (0%)
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 43.7 to 49.5
Stabilization Target: $101.74 (+13.3%)
PE Expansion Potential: +13.3%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: September 13, 2026 5:50 AM ET
Data refreshes hourly during market hours. Next update: 6:50 AM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for AGL.

Create Free Account

Already have an account? Log In

Top Rated Medical Care Facilities Stocks

Top-rated stocks in Medical Care Facilities by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
THC
Tenet Healthcare Corporaâ€Ļ
STRONG BUY
22 analysts
$285 61 BUY
HCA
HCA Healthcare, Inc.
BUY
25 analysts
$451 50 HOLD
EHC
Encompass Health Corp
STRONG BUY
12 analysts
$148 55 HOLD
CMPS
Compass Pathways Plc
STRONG BUY
11 analysts
$24 52 HOLD
ADUS
Addus HomeCare Corporatiâ€Ļ
STRONG BUY
11 analysts
$135 56 HOLD

Advanced AGL Option Strategies

Professional options setups generated by AI based on today's AGL price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for AGL

AGL Technical Chart AGL Price Prediction AGL Earnings Date AGL Investment Advisor AGL Fair Price Analyzer AGL Options Advisor AGL Options Chain AGL Options Analysis AGL Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals